ID

14492

Descripción

A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands; ODM derived from: https://clinicaltrials.gov/show/NCT00657774

Link

https://clinicaltrials.gov/show/NCT00657774

Palabras clave

  1. 18/4/16 18/4/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

18 de abril de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Asthma NCT00657774

Eligibility Asthma NCT00657774

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00657774
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 18-65 at the screening visit;
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
history of asthma for at least 6 months prior to screening visit
Descripción

history of asthma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0004096
UMLS CUI [1,3]
C0040223
well controlled asthma with rescue short acting beta agonist (albuterol) and or stable doses of other medications for at least 4 weeks prior to screening visit
Descripción

short acting beta agonist

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001927
female subjects that are not pregnant or lactating
Descripción

pregnancy or lactation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
otherwise healthy as determined by the investigator.
Descripción

healthy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1708335
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
life-threatening asthma within the past year or visit to emergency room for asthma in the past 3 months prior to the screening visit;
Descripción

life-threatening asthma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C2826244
UMLS CUI [1,3]
C0040223
UMLS CUI [2]
C0583237
significant,nonreversible pulmonary disease (e.g. chronic obstructive pulmonary disease, cystic fibrosis or bronchiectasis)
Descripción

pulmonary disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0024115
use of any steroid medications, topical or inhaled steroids within 4 weeks or systemic (oral or injectable) steroids within 3 months of dosing
Descripción

steroid

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038317
an upper or lower respiratory tract infection within the last 4 weeks pior to screening visit or acute illness or infection within 6 weeks prior to dosing
Descripción

respiratory tract infection comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0035243
UMLS CUI [1,2]
C0040223
UMLS CUI [2]
C0009488
any significant disease or major disorder that may jeopardize subject safety
Descripción

comorbidity limiting study protocol

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348563
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
history of tabacco use within 6 months prior to dosing and/or smoking history > 10 pack-years
Descripción

smoking history

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1519384
UMLS CUI [1,2]
C1277691
UMLS CUI [1,3]
C0040223
female subjects on hormone replacement therapy or using birth control involving hormones in the past 6 months
Descripción

hormone replacement therapy hormonal contraception

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0282402
UMLS CUI [2]
C2985296
additional inclusion and exclusion criteria will evaluated by the investigator.
Descripción

criteria

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0242801

Similar models

Eligibility Asthma NCT00657774

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00657774
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
age 18-65 at the screening visit;
boolean
C0001779 (UMLS CUI [1])
history of asthma
Item
history of asthma for at least 6 months prior to screening visit
boolean
C0262926 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
short acting beta agonist
Item
well controlled asthma with rescue short acting beta agonist (albuterol) and or stable doses of other medications for at least 4 weeks prior to screening visit
boolean
C0001927 (UMLS CUI [1])
pregnancy or lactation
Item
female subjects that are not pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
healthy
Item
otherwise healthy as determined by the investigator.
boolean
C1708335 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
life-threatening asthma
Item
life-threatening asthma within the past year or visit to emergency room for asthma in the past 3 months prior to the screening visit;
boolean
C0004096 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
C0583237 (UMLS CUI [2])
pulmonary disease
Item
significant,nonreversible pulmonary disease (e.g. chronic obstructive pulmonary disease, cystic fibrosis or bronchiectasis)
boolean
C0024115 (UMLS CUI [1])
steroid
Item
use of any steroid medications, topical or inhaled steroids within 4 weeks or systemic (oral or injectable) steroids within 3 months of dosing
boolean
C0038317 (UMLS CUI [1])
respiratory tract infection comorbidity
Item
an upper or lower respiratory tract infection within the last 4 weeks pior to screening visit or acute illness or infection within 6 weeks prior to dosing
boolean
C0035243 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0009488 (UMLS CUI [2])
comorbidity limiting study protocol
Item
any significant disease or major disorder that may jeopardize subject safety
boolean
C2348563 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
smoking history
Item
history of tabacco use within 6 months prior to dosing and/or smoking history > 10 pack-years
boolean
C1519384 (UMLS CUI [1,1])
C1277691 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
hormone replacement therapy hormonal contraception
Item
female subjects on hormone replacement therapy or using birth control involving hormones in the past 6 months
boolean
C0282402 (UMLS CUI [1])
C2985296 (UMLS CUI [2])
criteria
Item
additional inclusion and exclusion criteria will evaluated by the investigator.
boolean
C0242801 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial